Johnson & Johnson Articles
J&J begins tender offer for Mentor
22 December 2008
J&J agrees to buy Mentor for $1.07B
8 December 2008
J&J unit "tapped" for funds by pediatrician
8 December 2008
Catalyst Biosciences raises $40 million
8 December 2008
Indonesia tells drug firms: "invest or go"
8 December 2008
J&J makes $438M bid for Omrix
1 December 2008
EMEA suspends J&J's Ionsys on defects
1 December 2008
Yondelis approved in Russia for STS
1 December 2008
CHMP positive opinion for Tibotec's Prezista
1 December 2008
Stock Commentary - New York week to Nov 24, 2008
1 December 2008
Ortho Biotech files trabectedin NDA
1 December 2008
FDA approves J&J's tapentadol
1 December 2008
J&J's Prezista non-inferior to lopinavir
1 December 2008
Janssen's mixed bag from CHMP meeting
1 December 2008
Pfizer withdraws OTC Viagra EU application
1 December 2008
J&J subsidiaries ordered to pay $16.6M over Duragesic death
24 November 2008
J&J/Basilea's ceftobiprole gets first European approval as Swissmedic clears it for cSSI
24 November 2008
US firm Cynvec appoints Frank Stonebanks as CEO
17 November 2008
Paliperidone ER helps schizoaffective disorder
10 November 2008
Zeltia's 3rd-qtr sales jump 24% on Yondelis
10 November 2008
UK cancer groups turn against Celgene over NICE refusal
10 November 2008
EC broadens Prezista indication
8 November 2008
Perrigo licenses Rx brands to Medimetriks
3 November 2008
J&J submits NDA for carisbamate for partial onset seizures
3 November 2008
Electronic drug alert goes live in USA
3 November 2008
Prezista achieves non-inferior virologic response to lopinavir
3 November 2008
US FDA grants J&J's Prezista expanded label
27 October 2008
Humira shows three year fistula effect
27 October 2008
Tibotec begins REALIZE trial enrollment
27 October 2008
WuXi expands R&D collaboration with J&J
20 October 2008
J&J promotes Sheri McCoy to pharmaceuticals chairman
20 October 2008
Omrix gets EU approval for Evicel sealant
20 October 2008
Summit signs zebrafish platform deal with J&J
20 October 2008
FDA approval for new Risperdal injection site
20 October 2008
Pharma "a nice juicy target" for "Pres" Obama, DTC expert claims, TV and social media hit
20 October 2008
Japan sees growth in nicotine patch market
13 October 2008
Johnson & Johnson Diabetes Institute launched
13 October 2008
SONIC trial data "could challenge treatment protocol" for CD
13 October 2008
J&J launches Doribax in UK
6 October 2008
Belgium launches pharma R&D campaign
6 October 2008
UK's NICE says "Yes" to some drugs
29 September 2008
J&J's epoetin-alfa linked to deaths in stroke trial
22 September 2008
US
22 September 2008
Mylan's generic Risperdal cleared by FDA
22 September 2008
Bayer tops most-visited European pharma web sites
22 September 2008
EC approves expanded indication for Velcade
15 September 2008
US FDA calls for tougher warnings on TNF-alpha drugs on 240 cases of histoplasmosis
15 September 2008
Ortho-McNeil to appeal Razadyne patent ruling
8 September 2008
FDA delay for J&J's Doribax
1 September 2008
Delay for J&J's schizophrenia injection
1 September 2008
Novosom gets rights to Isis' targeted CD40 mRNA
1 September 2008
Thomson releases Pharma Matters reports for 1st qtr
1 September 2008
Rumors of takeover bid for Omrix
1 September 2008
Drug majors protest FASB legal cost disclosure plan
18 August 2008
Teva's 2nd-qtr 2008 profit up 5% to $539M
18 August 2008
Boehringer's first-half 2008 profit drops 10%
18 August 2008
FDA extends review of BLA for ustekinumab
18 August 2008
Boehringer's first-half 2008 profit drops 10%
18 August 2008
Zeltia gains on plan for Yondelis label expansion
18 August 2008
76% of TMC278 patients achieve undetectable HIV
18 August 2008
Alkermes/J&J's Vivitrol approved in Russia
11 August 2008
J&J licenses Amgen drug for up to $435M
11 August 2008
Zeltia's first-half 2008 income surges up 40%
11 August 2008
J&J/Bayer's anticoagulant submitted for approval in USA
4 August 2008
Bayer/J&J's Xarelto gets nod from CHMP
4 August 2008
Indian biotech firm Biocon ranked among world's top 10
4 August 2008
Vanda's shares halve on US iloperidone setback
4 August 2008
Basilea's 2nd-qtr net loss widens 5.4%
4 August 2008
ABPI joined by 16 new members in 1H 2008
4 August 2008
NICE rejects second-line use of TNF-alpha drugs
28 July 2008
Stock Commentary - New York week to July 14, 2008
21 July 2008
Amgen and Ortho Bio settle antitrust suit
21 July 2008
Focalin XR manages ADHD better than Concerta ER
21 July 2008
Kuros recruits Beat Neukom as new CFO
14 July 2008
Clarification: GSK OTC smoking cessation drug
14 July 2008
Black box warnings on fluoroquinolone
14 July 2008
UK doctors debate NHS drug top-ups
14 July 2008
UK doctors debate NHS drug top-ups
14 July 2008
J&J unit gets offer for Wound Care business
7 July 2008
Eisai's Aciphex cleared for GERD by US FDA
7 July 2008
Basilea/J&J's ceftobiprole approved in Canada
7 July 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
